As of January 22, 2025, Tango Therapeutics (TNGX) has a market cap of $0.33 billion USD. According to our data, Tango Therapeutics is ranked No.6576 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.33 B |
-0.32%
|
Dec 31, 2024 | $0.33 B |
-68.79%
|
Dec 29, 2023 | $1.06 B |
36.55%
|
Dec 30, 2022 | $0.78 B |
-33.73%
|
Dec 31, 2021 | $1.18 B |
-4.37%
|
Dec 31, 2020 | $1.23 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Repare Therapeutics
RPTX
|
$51.44 M |
0.000 M
|
Canada
|
Kronos Bio
KRON
|
$60.34 M |
0.000 M
|
USA
|
G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
Market Cap | = | TNGX Stock Price | * | TNGX Shares Outstanding |
= | $3.08 | * | 0.11 B | |
= | $0.33 B |